| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| CDK8-IN-13 |
化合物CDK8-IN-13 |
918523-75-8 |
詳細(xì)
|
| Prostaglandin D2 Synthase Protein, Human, Recombinant (His) |
PROSTAGLANDIN D2 SYNTHASE, HUMAN, 重組蛋白 (HIS) |
|
詳細(xì)
|
| octanal |
正辛醛 |
124-13-0 |
詳細(xì)
|
| (±)14-HDHA |
(±)14-HDHA |
87042-40-8 |
詳細(xì)
|
| CTB |
N-(4-Chloro-3-trifluoromethyl-phenyl)-2-ethoxy-benzamide |
451491-47-7 |
詳細(xì)
|
| Rp-8-bromo-Cyclic AMPS (sodium salt) |
RP-8-BROMO-CYCLIC AMPS SODIUM SALT |
925456-59-3 |
詳細(xì)
|
| Femoxetine |
非莫西汀 |
59859-58-4 |
詳細(xì)
|
| FA16 |
化合物FA16 |
|
詳細(xì)
|
| Perlapine |
perlapine |
1977-11-3 |
詳細(xì)
|
| TGF beta 3 Protein, Human/Mouse/Rat, Recombinant |
TGF BETA 3, HUMAN/MOUSE/RAT, 重組蛋白 |
|
詳細(xì)
|
| Thalidomide-5-OH |
4 - 羥基沙利度胺 |
64567-60-8 |
詳細(xì)
|
| BCAT-IN-2 |
BCAT-IN-2 |
1800024-45-6 |
詳細(xì)
|
| CAY10767 |
Benzoic acid, 3-[[[4-[(4-fluorophenyl)methoxy]-3-methylphenyl]methyl]amino]- |
2376590-40-6 |
詳細(xì)
|
| 1,3,6,8-Pyrenetetrasulfonic Acid (sodium salt hydrate) |
1,3,6,8-PYRENETETRASULFONIC ACID (SODIUM SALT HYDRATE) |
1771776-02-3 |
詳細(xì)
|
| TDO-IN-1 |
化合物 TDO-IN-1 |
2490672-92-7 |
詳細(xì)
|
| Sulfo-SANPAH Crosslinker |
6-[(4-疊氮-2-硝基苯基)氨基]己酸磺酸基琥珀酰亞胺酯 |
102568-43-4 |
詳細(xì)
|
| Gizzerosine HCl |
化合物 GIZZEROSINE 2HCL |
103548-49-8 |
詳細(xì)
|
| Ethoxyquin Dimer |
乙氧基喹啉二聚體 |
74681-77-9 |
詳細(xì)
|
| (S)-Acenocoumarol |
(S)-(-)-Nicoumalone |
66556-78-3 |
詳細(xì)
|
| ECBN HCL |
1-[(4R,5R)-4,5-二羥基-L-鳥氨酸]棘白菌素 B 鹽酸鹽 |
1029890-89-8 |
詳細(xì)
|
| Linagliptin Methyldimer |
LINAGLIPTIN METHYLDIMER |
1418133-47-7 |
詳細(xì)
|
| Rovatirelin |
4-Oxazolidinecarboxamide, 5-methyl-N-[(1S)-2-[(2R)-2-methyl-1-pyrrolidinyl]-2-oxo-1-(4-thiazolylmethyl)ethyl]-2-oxo-, (4S,5S)- |
204386-76-5 |
詳細(xì)
|
| TP-064 |
TP-064 |
2080306-20-1 |
詳細(xì)
|
| GP130 receptor agonist-1 |
UCLA GP130 2 |
339303-87-6 |
詳細(xì)
|
| AMI-193 |
螺哌丙苯 |
510-74-7 |
詳細(xì)
|
| MAGL-IN-4 |
His121 ARG57 |
2135785-20-3 |
詳細(xì)
|
| BI-4142 |
BI-4142 |
2682003-36-5 |
詳細(xì)
|
| Opevesostat |
/ |
2231294-96-3 |
詳細(xì)
|
| PDS-0330 |
N-((4-(苯并[D]惡唑-2-基)苯基)硫代氨基甲?；?-2-萘甲酰胺 |
2904682-19-3 |
詳細(xì)
|
| 3-(2-aminopropyl)phenol hydrochloride |
3-(2-氨基丙基)苯酚鹽酸 |
54779-56-5 |
詳細(xì)
|
| TAK-653 |
9-(4-(環(huán)己氧基)苯基)-7-甲基-3,4-二氫吡嗪[2,1-C][1,2,4]噻二嗪-2,2-二氧化物 |
1358751-06-0 |
詳細(xì)
|
| Metapramine |
美他帕明 |
21730-16-5 |
詳細(xì)
|
| AUTAC1 |
化合物 AUTAC1 |
2241669-09-8 |
詳細(xì)
|
| CFTR corrector 9 |
化合物 CFTR CORRECTOR 9 |
909861-78-5 |
詳細(xì)
|
| Cibisatamab |
賽必妥單抗 |
1855925-27-7 |
詳細(xì)
|
| Biotin-TAT (47-57) acetate |
化合物BIOTIN-TAT (47-57) ACETATE |
|
詳細(xì)
|
| H-Lys-Trp-Lys-OH acetate |
化合物 H-LYS-TRP-LYS-OH ACETATE |
|
詳細(xì)
|
| ITGB1 Protein, Human, Recombinant (His) |
ITGB1, HUMAN, 重組蛋白 (HIS) |
|
詳細(xì)
|
| α-Conotoxin Vc1.1 TFA |
|
|
詳細(xì)
|
| Ot-730 HCl |
OT-730鹽酸鹽 |
|
詳細(xì)
|
| Pregnenolone Carbonitrile |
5-孕烷-3Β-醇-20-酮-16Α-腈 |
1434-54-4 |
詳細(xì)
|
| CAY10404 |
3-(4-METHYLSULPHONYLPHENYL)-4-PHENYL-5-TRIFLUOROMETHYLISOXAZOLE |
340267-36-9 |
詳細(xì)
|
| 15(S)-15-methyl Prostaglandin E2 |
15(S)-15-METHYL PROSTAGLANDIN E2 |
35700-27-7 |
詳細(xì)
|
| BIIB068 |
BIIB068 |
1798787-27-5 |
詳細(xì)
|
| 6-HYDROXYLAMINOURACIL |
6-HYDROXYLAMINOURACIL |
20555-88-8 |
詳細(xì)
|
| 2α-Mannobiose |
2-O-(Α-D-吡喃甘露糖基)-D-吡喃甘露糖 |
15548-39-7 |
詳細(xì)
|
| GLPG3970 |
3,4-二氫-8-甲氧基-6-[7-[2-(4-嗎啉基)乙氧基]咪唑并[1,2-A]吡啶-3-基]-2-(2,2,2-三氟乙基)-1(2H)-異喹啉酮 |
2403733-82-2 |
詳細(xì)
|
| Pomalidomide-C5-COOH |
化合物POMALIDOMIDE-C5-COOH |
|
詳細(xì)
|
| Rotigaptide TFA(355151-12-1 free base) |
化合物ROTIGAPTIDE TFA |
|
詳細(xì)
|
| Paclobutrazol |
多效唑 |
76738-62-0 |
詳細(xì)
|
| Pirmagrel |
吡嗎格雷 |
85691-74-3 |
詳細(xì)
|
| DN401 |
化合物DN401 |
2135749-60-7 |
詳細(xì)
|
| CD32B/Fcgr2b Protein, Mouse, Recombinant (His) |
CD32B/FCGR2B, MOUSE, 重組蛋白 (HIS) |
|
詳細(xì)
|
| Jasmonic acid |
(+-)-茉莉酸 |
6894-38-8 |
詳細(xì)
|
| HALOFUGINONE LACTATE |
常山酮內(nèi)酯 |
82186-71-8 |
詳細(xì)
|
| (S)-p38 MAPK Inhibitor III |
p38 MAP Kinase Inhibitor III |
581098-48-8 |
詳細(xì)
|
| 1,2-bis(heptanoylthio) Glycerophosphocholine |
1,2-BIS(HEPTANOYLTHIO)GLYCEROPHOSPHOCHOLINE |
89019-63-6 |
詳細(xì)
|
| (±)-Acetylcarnitine chloride |
ACETYL-DL-CARNITINE HYDROCHLORIDE |
2504-11-2 |
詳細(xì)
|
| Gramicidin A |
甲胎蛋白 |
11029-61-1 |
詳細(xì)
|
| Telazorlimab |
特拉佐利單抗 |
2126777-87-3 |
詳細(xì)
|
| SOS1-IN-11 |
SOS1 抑制劑 |
2654741-64-5 |
詳細(xì)
|
| CB2R/FAAHmodulator-1 |
CB2R/FAAH調(diào)節(jié)劑-1 |
928892-60-8 |
詳細(xì)
|
| CGP 3466B maleate |
TCH 346 MALEATE; CGP3466B; CGP-3466B; TCH346; TCH-346 |
200189-97-5 |
詳細(xì)
|
| CP 461 |
OSI-461 |
227619-96-7 |
詳細(xì)
|
| ACT-373898 |
ACT 373898 |
1433875-14-9 |
詳細(xì)
|
| Cyanidin 3-O-arabinoside |
矢車菊素-3-O-阿拉伯糖苷 |
792868-19-0 |
詳細(xì)
|
| Cromolyn (sodium salt hydrate) |
|
|
詳細(xì)
|
| Senaparib |
Senaparib |
1401682-78-7 |
詳細(xì)
|
| Bemarituzumab |
貝馬里妥珠單抗 |
1952272-74-0 |
詳細(xì)
|
| Vofatamab |
VOFATAMAB (沃凡妥單抗 ) |
1312305-12-6 |
詳細(xì)
|
| GRO beta/CXCL2 Protein, Human, Recombinant |
GRO BETA/CXCL2, HUMAN, 重組蛋白 |
|
詳細(xì)
|
| L-Iduronic acid sodium salt |
L-艾杜糖醛酸 |
61199-83-5 |
詳細(xì)
|
| CAY10665 |
(11Z)-16-[[2-(MethylaMino)-2-oxoacetyl]aMino]-11-hexadecenoic Acid |
1235543-17-5 |
詳細(xì)
|
| Sulfo-NHS-LC-Biotin sodium |
生物素化-EPSILON-氨基己酸-N-羥基磺基丁二酰亞胺活化酯 |
191671-46-2 |
詳細(xì)
|
| hMAO-B-IN-4 |
化合物HMAO-B-IN-4 |
1666119-75-0 |
詳細(xì)
|
| 4-isocyanato TEMPO |
4-ISOCYANATO-TEMPO |
88418-69-3 |
詳細(xì)
|
| Oxelumab |
OXELUMAB ( 奧塞蘆單抗 ) |
1186098-83-8 |
詳細(xì)
|
| Neurotensin(8-13) 3TFA(60482-95-3(free base)) |
Neurotensin(813) 3TFA(60482953(free base)),Neurotensin(8 13) 3TFA(60482 95 3(free base)) |
2952825-79-3 |
詳細(xì)
|
| NRX-252114 |
化合物NRX-252114 |
2763260-39-3 |
詳細(xì)
|
| TSLP Protein, Mouse, Recombinant (His) |
TSLP, MOUSE, 重組蛋白 (HIS) |
|
詳細(xì)
|
| TJ08 |
化合物 TJ08 |
2924274-19-9 |
詳細(xì)
|
| L-SelenoMethionine |
L-硒代蛋氨酸 |
3211-76-5 |
詳細(xì)
|
| 17(R)-Resolvin D1 |
7S,8R,17R-TRIHYDROXY-4Z,9E,11E,13Z,15E19Z-DOCOSAHEXAENOIC ACID |
528583-91-7 |
詳細(xì)
|
| SIB 1553A |
化合物 SIB 1553A |
191611-76-4 |
詳細(xì)
|
| Noladin ether |
NOLADIN ETHER |
222723-55-9 |
詳細(xì)
|
| N-Nitroso Sarcosine |
N-亞硝基肌氨酸 |
13256-22-9 |
詳細(xì)
|
| MitoBloCK-11(MB-11) |
2-((4-溴萘-1-基)氧基)-N'-((5-硝基噻吩-2-基)亞甲基)乙酰肼 |
413606-16-3 |
詳細(xì)
|
| XY028-140 |
化合物XY028-140 |
2229974-83-6 |
詳細(xì)
|
| MRTX1133 |
MRTX1133 |
2621928-55-8 |
詳細(xì)
|
| Xinidamine |
希尼達(dá)明 |
50264-78-3 |
詳細(xì)
|
| 4-Chlorothieno[3,2-d]pyrimidine |
4-氯噻吩并[3,2-d]嘧啶 |
16269-66-2 |
詳細(xì)
|
| TGFβ1-IN-2 |
TGFΒ1抑制劑2 |
2700263-58-5 |
詳細(xì)
|
| N-Feruloylserotonin |
N-阿魏羥色胺 |
68573-23-9 |
詳細(xì)
|
| FR054 |
(3aR)-2-Methyl-5α-(acetoxymethyl)-6β,7α-diacetoxy-3aα,6,7,7aα-tetrahydro-5H-pyrano[3,2-d]oxazole |
35954-65-5 |
詳細(xì)
|
| N-Acetylthyroxine |
N-乙?；鵏-甲狀腺素 |
26041-51-0 |
詳細(xì)
|
| Aldehyde Reactive Probe TFA |
ARP |
627090-10-2 |
詳細(xì)
|
| Propargylcholine |
N-(2-羥乙基)-N,N-二甲基-2-丙炔-1-溴化銨 |
111755-76-1 |
詳細(xì)
|
| TBAP-001 |
1777832-90-2 |
1777832-90-2 |
詳細(xì)
|
| Pumecitinib |
化合物PUMECITINIB |
2401057-12-1 |
詳細(xì)
|